Sarah Carmody | Executive Director, IR & Corporate Communications |
Anna Protopapas | President, CEO & Director |
Arvin Yang | SVP & Chief Medical Officer |
Timothy Lowinger | Chief Science & Technology Officer |
Brian DeSchuytner | SVP & CFO |
Boris Peaker | Cowen and Company |
Kaveri Pohlman | BTIG |
Daniel Wolle | JPMorgan Chase & Co. |
Colleen Kusy | Robert W. Baird & Co. |
Good morning, and welcome to Mersana Therapeutics' Third Quarter 2021 Conference Call Webcast. I would now like to turn the call over to Sarah Carmody, Executive Director, Investor Relations and Corporate Communications. Please proceed.
Good morning. Welcome to Mersana's third Quarter 2021 Conference Call.